idec
RSS
High-tech jacuzzi system for uber-rich poochies
Jun 13 2008, Deepa

As much as we all love for our furry friends to smell fresh and clean, getting to that point isn’t always easy. Dogs aren’t always game to jump into the bathtub for a good scrub. And with an array of bath accessories available off shelves, it’s...

Related Stories
Most Recent Most Popular Most Commented
(0)
Biogen Idec 1Q profit rises 50 percent
AP, New York
Biogen Idec says its first-quarter profit rose 50 percent, boosted by further sales increases for the multiple sclerosis drug Avonex.
Earns, Biogen, Idec, Business
made popular Apr 16 2009
(0)
Biogen's 4Q profit grows as Icahn makes power play
AP, New York
Activist investor Carl Icahn made another power play for Biogen Idec Inc. Friday as the company said its fourth-quarter profit edged up 3 percent and 2009 results could...
Earns, Biogen, Idec, Business
made popular Feb 6 2009
(0)
Biogen Idec 4Q profit grew 3 pct
AP, New York
Biogen Idec Inc. says its fourth-quarter profit rose 3 percent on better sales of its multiple sclerosis drugs, and forecast profit for this year that topped analyst...
Earns, Biogen, Idec, Business
made popular Feb 6 2009
(0)
Biogen 3Q profit rises 73 percent, tops forecast
AP, Cambridge
Biogen Idec Inc.’s third-quarter profit surged 73 percent on higher sales of the multiple sclerosis drugs Avonex and Tysabri, topping Wall Street forecasts and...
Earns, Biogen, Idec, Business
made popular Oct 21 2008
(1)
Biogen Idec, Elan report 2 cases of brain disease
AP, New York
Shares of Biogen Idec Inc. and Elan Corp. PLC plunged after-hours Thursday after the companies reported two new cases of a brain disease in patients treated with their...
Biogen, Idec, Elan, Drug
made popular Jul 31 2008
(0)
Icahn loses campaign to change Biogen Idec board
AP, Cambridge
Carl Icahn lost his campaign to elect a slate of dissident nominees to Biogen Idec Inc.’s board on Thursday, an effort the activist investor hoped would...
Biogen, Idec, Icahn, Business
made popular Jun 19 2008
(0)
Icahn concedes defeat in Biogen Idec campaign
AP, Cambridge
Activist investor Carl Icahn has conceded defeat in his campaign to elect a slate of dissident nominees to Biogen Idec Inc.’s board.One of Icahn’s nominees,...
Biogen, Idec, Icahn, Business
made popular Jun 19 2008
(0)
Biogen Says It Plans to Stay Independent
AP, Boston
Two months after Biogen Idec Inc. said it was considering putting itself up for sale, the biotechnology company said it will remain independent, sending its shares...
NorthAmerica, United States, Biogen, Idec
made popular Dec 13 2007
(0)
Biogen Ends Review, No Plan to Sell
AP, Cambridge
Biogen Idec Inc. said Wednesday it will remain an independent company after a search for a possible buyer failed to yield any definitive offers. The biotechnology...
NorthAmerica, United States, Biogen, Idec
made popular Dec 12 2007
(0)
Biogen Idec Exploring Potential Sale
AP, Boston
Biotechnology firm Biogen Idec Inc. said Friday it was exploring a possible sale of the company and already has interest from billionaire investor Carl Icahn, who has...
NorthAmerica, United States, Biogen, Idec
made popular Oct 12 2007
All Stories
Most Recent Most Popular Most Commented
(0)
Biogen Idec 1Q profit rises 50 percent
AP, New York
Biogen Idec says its first-quarter profit rose 50 percent, boosted by further sales increases for the multiple sclerosis drug Avonex.
Earns, Biogen, Idec, Business
made popular Apr 16 2009
(0)
Biogen's 4Q profit grows as Icahn makes power play
AP, New York
Activist investor Carl Icahn made another power play for Biogen Idec Inc. Friday as the company said its fourth-quarter profit edged up 3 percent and 2009 results could...
Earns, Biogen, Idec, Business
made popular Feb 6 2009
(0)
Biogen Idec 4Q profit grew 3 pct
AP, New York
Biogen Idec Inc. says its fourth-quarter profit rose 3 percent on better sales of its multiple sclerosis drugs, and forecast profit for this year that topped analyst...
Earns, Biogen, Idec, Business
made popular Feb 6 2009
(0)
Biogen 3Q profit rises 73 percent, tops forecast
AP, Cambridge
Biogen Idec Inc.’s third-quarter profit surged 73 percent on higher sales of the multiple sclerosis drugs Avonex and Tysabri, topping Wall Street forecasts and...
Earns, Biogen, Idec, Business
made popular Oct 21 2008
(1)
Biogen Idec, Elan report 2 cases of brain disease
AP, New York
Shares of Biogen Idec Inc. and Elan Corp. PLC plunged after-hours Thursday after the companies reported two new cases of a brain disease in patients treated with their...
Biogen, Idec, Elan, Drug
made popular Jul 31 2008
(0)
Icahn loses campaign to change Biogen Idec board
AP, Cambridge
Carl Icahn lost his campaign to elect a slate of dissident nominees to Biogen Idec Inc.’s board on Thursday, an effort the activist investor hoped would...
Biogen, Idec, Icahn, Business
made popular Jun 19 2008
(0)
Icahn concedes defeat in Biogen Idec campaign
AP, Cambridge
Activist investor Carl Icahn has conceded defeat in his campaign to elect a slate of dissident nominees to Biogen Idec Inc.’s board.One of Icahn’s nominees,...
Biogen, Idec, Icahn, Business
made popular Jun 19 2008
(0)
Biogen Says It Plans to Stay Independent
AP, Boston
Two months after Biogen Idec Inc. said it was considering putting itself up for sale, the biotechnology company said it will remain independent, sending its shares...
NorthAmerica, United States, Biogen, Idec
made popular Dec 13 2007
(0)
Biogen Ends Review, No Plan to Sell
AP, Cambridge
Biogen Idec Inc. said Wednesday it will remain an independent company after a search for a possible buyer failed to yield any definitive offers. The biotechnology...
NorthAmerica, United States, Biogen, Idec
made popular Dec 12 2007
(0)
Biogen Idec Exploring Potential Sale
AP, Boston
Biotechnology firm Biogen Idec Inc. said Friday it was exploring a possible sale of the company and already has interest from billionaire investor Carl Icahn, who has...
NorthAmerica, United States, Biogen, Idec
made popular Oct 12 2007
Related Tags
activist Avonex biogen Biogen Idec Biogen Idec Friday Boston Business Cambridge Carl Icahn earns Elan Corp PLC Europe icahn New York North America sale Tysabri United Kingdom United States Wall Street
FAQ / Help
Move to top